Unresolved issues in diagnosis and management of inherited bleeding disorders in the perinatal period: A white paper of the Perinatal Task Force of the Medical and Scientific Advisory Council of the National Hemophilia Foundation, USA

Haemophilia

Volumn 12, Issue 3, 2006, Pages 205-211

  Kulkarni, Roshni ^a   Ponder, K P ^b   James, A H ^c   Soucie, J M ^d   Koerper, M ^e   Hoots, W K ^f   Lusher, J M ^g  

^a MICHIGAN STATE UNIVERSITY   (United States)

^b GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

^d CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f UNIVERSITY OF TEXAS   (United States)

^g WAYNE STATE UNIVERSITY   (United States)

Author keywords

Bleeding; Carrier; Haemophilia; Intracranial hemorrhage; Neonatal; Pregnancy

Indexed keywords

BLOOD CLOTTING FACTOR 7; BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 8 CONCENTRATE; BLOOD CLOTTING FACTOR 9; BLOOD CLOTTING FACTOR 9 CONCENTRATE; RECOMBINANT BLOOD CLOTTING FACTOR 7A;

BLOOD CLOTTING DISORDER; BRAIN HEMORRHAGE; DELIVERY; HEMOPHILIA; HETEROZYGOTE; HETEROZYGOTE DETECTION; HUMAN; MOTHER; NEONATAL HEMORRHAGE; NONHUMAN; OBSTETRIC CARE; PERINATAL PERIOD; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; REVIEW; RISK FACTOR;

ADULT; ADVISORY COMMITTEES; BLOOD COAGULATION FACTORS; DELIVERY, OBSTETRIC; FEMALE; GENE THERAPY; HEMOPHILIA A; HEMORRHAGE; HETEROZYGOTE DETECTION; HUMANS; INFANT, NEWBORN; INTRACRANIAL HEMORRHAGES; PREGNANCY; PRENATAL DIAGNOSIS; RESEARCH;

EID: 33645995723     PISSN: 13518216     EISSN: 13652516     Source Type: Journal    
DOI: 10.1111/j.1365-2516.2006.01277.x     Document Type: Review

References (28)

1. Chalmers EA. Neonatal coagulation problems. Arch Dis Child Fetal Neonatal Ed 2004; 89: F475-8.
2. Kadir RA, Economides DL, Braithwaite J, Goldman E, Lee CA. The obstetric experience of carriers of haemophilia. Br J Obstet Gynaecol 1997; 104: 803-10.
3. Yang MY, Ragni MV. Clinical manifestations and management of labor and delivery in women with factor IX deficiency. Haemophilia 2004; 10: 483-90.
4. Guy GP, Baxi LV, Hurlet-Jensen A, Chao CR. An unusual complication in a gravida with factor IX deficiency: Case report with review of the literature. Obstet Gynecol 1992; 80: 502-5.
5. Mauser Bunschoten EP, van Houwelingen JC, Sjamsoedin Visser EJ, van Dijken PJ, Kok AJ, Sixma JJ. Bleeding symptoms in carriers of hemophilia A and B. Thromb Haemost 1988; 59: 349-52.
6. Greer IA, Lowe GD, Walker JJ, Forbes CD. Haemorrhagic problems in obstetrics and gynaecology in patients with congenital coagulopathies. Br J Obstet Gynaecol 1991; 98: 909-18.
7. Ludlam CA, Pasi KJ, Bolton-Maggs P et al.; UK Haemophilia Centre Doctors' Organisation. A framework for genetic service provision for haemophilia and other inherited bleeding disorders. Haemophilia 2005; 11: 145-63.
8. Kadir RA. Women and inherited bleeding disorders: Pregnancy and delivery. Semin Hematol 1999; 36: 28-35.
9. Lavery S. Preimplantation genetic diagnosis: New reproductive options for carriers of haemophilia. Haemophilia 2004; 10: 126-32.
10. MacLean PE, Fijnvandraat K, Beijlevelt M, Peters M. The impact of unaware carriership on the clinical presentation of haemophilia. Haemophilia 2004; 10: 560-4.
11. Ljung R, Lindgren AC, Petrini P, Tengborn L. Normal vaginal delivery is to be recommended for haemophilia carrier gravidae. Acta Paediatr 1994; 83: 609-11.
12. Chalmers EA. Haemophilia and the newborn. Blood Rev 2004; 18: 85-92.
13. Kulkarni R, Lusher J. Perinatal management of newborns with haemophilia. Br J Haematol 2001; 112: 264-74.
14. Brugnara C, Platt OS. The neonatal erythrocyte and its disorders. In: Nathan DG, Orkin SH et al, eds. Nathan and Oski's Hematology of Infancy and Childhood. Philadelphia, PA: WB Saunders, 2003: 19-55.
15. Towner D, Castro MA, Eby-Wilkens E et al. Effect of mode of delivery in nulliparous women on neonatal intracranial injury. New Engl J Med 1999; 341: 1709-14.
16. Kulkarni R, Lusher JM. Intracranial and extracranial hemorrhages in newborns with hemophilia: A review of the literature. J Pediatr Hematol Oncol 1999; 21: 289-95.
17. Kulkarni R, Lusher JM, Henry RC, Kallen DJ. Current practices regarding newborn intracranial haemorrhage and obstetrical care and mode of delivery of pregnant haemophilia carriers: A survey of obstetricians, neonatologists and haematologists in the United States, on behalf of the National Hemophilia Foundation's Medical and Scientific Advisory Council. Haemophilia 1999; 5: 410-5.
18. Klinge J, Auberger K, Auerswald G et al. Prevalence and outcome of intracranial hemorrhage in hemophiliacs - a survey of the paediatric group of the German Society for Thrombosis and Haemostasis (GTH). Eur J Paediatr 1999; 158: 1162-5.
19. Buchanan GR. Factor concentrate prophylaxis for neonates with hemophilia. J Pediatr Hematol Oncol 1999; 21: 254-6.
20. Chalmers EA et al. on behalf of the UKHCDO Paediatric Working Party. Management of neonates with inherited bleeding disorders - a survey of current UK practice. Haemophilia 2005; 11: 186-7.
21. Rodriguez V, Schmidt KA, Slaby JA, Pruthi RK. Intracranial haemorrhage as initial presentation of severe hemophilia B: Case report and review of Mayo Clinic Comprehensive Hemophilia Center experience. Haemophilia 2005; 11: 73-7.
22. Lorenzo JI, Lopez A, Altisent C, Aznar JA. Incidence of factor VIII inhibitors in severe haemophilia: The importance of patient age. Br J Haematol 2001; 113: 600-3.
23. van der Bom JG, Mauser-Bunschoten EP, Fischer K, van den Berg HM. Age at first treatment and immune tolerance to factor VIII in severe hemophilia. Thromb Haemost 2003; 89: 475-9.
24. Rivard GE, Lillicrap D, Poon MC et al. Can activated recombinant factor VII be used to postpone the exposure of infants to factor VIII until after 2 years of age? Haemophilia 2005; 11: 335-9.
25. Madoiwa S, Yamauchi T, Hakamata Y et al. Induction of immune tolerance by neonatal intravenous injection of human factor VIII in murine hemophilia A. J Thromb Haemost 2004; 2: 754-62. Erratum in: J Thromb Haemost., 2004; 2: 1504.
26. Russell KE, Olsen EH, Raymer RA et al. Reduced bleeding events with subcutaneous administration of recombinant human factor IX in immune-tolerant hemophilia B dogs. Blood 2003; 102: 4393-8.
27. Zhang J, Xu L, Haskins ME, Ponder KP. Neonatal gene transfer with a retroviral vector results in tolerance to human factor IX in mice and dogs. Blood 2004; 103: 143-51.
28. Guilcher GMT, Scully MF, Harvey M, Hand JP. Treatment of intracranial and extracranial hemorrhages in a neonate with severe hemophilia B with recombinant factor IX infusion. Haemophilia 2005; 11: 411-4.